Lv42
460 积分 2025-05-07 加入
Ablation of FAS confers allogeneic CD3– CAR T cells with resistance to rejection by T cells and natural killer cells
10天前
已完结
ASB3 promotes hepatocellular carcinoma progression by mediating DR5 ubiquitination in TRAIL resistance
14天前
已完结
Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma
22天前
已完结
B-cells and their targeting in rheumatoid arthritis — Current concepts and future perspectives
28天前
已完结
A review of PD-1/PD-L1 siRNA delivery systems in immune T cells and cancer cells
1个月前
已完结
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
1个月前
已完结
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
1个月前
已完结
An innovative antibody fusion protein targeting PD-L1, VEGF and TGF-β with enhanced antitumor efficacies
1个月前
已完结
A Phase 1 Study of PIT565, a First-in-Class, Anti-CD3, Anti-CD19, Anti-CD2 Trispecific Antibody in Patients with Relapsed and/or Refractory B-Cell Malignancies
1个月前
已完结
PIT565, a First-in-Class Anti-CD19, Anti-CD3, Anti-CD2 Trispecific Antibody for the Treatment of B Cell Malignancies
1个月前
已完结
皖公网安备34019202002308
